Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) Director Howard Rubin sold 10,000 shares of the company's stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $34.50, for a total transaction of $345,000.00. Following the sale, the director directly owned 193,288 shares in the company, valued at $6,668,436. This trade represents a 4.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Trupanion Price Performance
NASDAQ TRUP traded up $0.39 on Tuesday, hitting $36.55. The stock had a trading volume of 451,793 shares, compared to its average volume of 440,404. The firm has a 50-day moving average of $27.89 and a 200-day moving average of $26.77. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.74 and a current ratio of 1.74. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $38.87. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 59.92, a price-to-earnings-growth ratio of 1.58 and a beta of 1.27.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The financial services provider reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.04. The firm had revenue of $405.59 million during the quarter, compared to analyst estimates of $402.53 million. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. During the same period in the previous year, the business earned $0.13 EPS. Equities analysts expect that Trupanion, Inc. will post 0.68 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new stake in Trupanion during the second quarter valued at about $4,631,000. Bank of America Corp DE bought a new stake in Trupanion during the second quarter worth about $14,262,000. Renaissancere Holdings Ltd. purchased a new position in shares of Trupanion in the 2nd quarter worth about $6,514,510. Legal & General Group Plc purchased a new position in shares of Trupanion in the 2nd quarter worth about $1,938,000. Finally, GSA Capital Partners LLP purchased a new position in shares of Trupanion in the 2nd quarter worth about $1,394,000.
Analyst Upgrades and Downgrades
TRUP has been the subject of several research analyst reports. Zacks Research lowered Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 24th. Wall Street Zen upgraded Trupanion from a "hold" rating to a "buy" rating in a research note on Saturday, November 7th. Weiss Ratings raised Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, September 29th. Cantor Fitzgerald raised their price target on Trupanion from $30.00 to $33.00 and gave the company a "neutral" rating in a report on Monday, November 9th. Finally, Stifel Nicolaus lifted their price target on Trupanion from $29.00 to $34.00 and gave the company a "hold" rating in a research report on Monday, November 9th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $40.00.
Get Our Latest Stock Report on Trupanion
Trupanion Company Profile
(
Get Free Report)
Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.